BCK Capital Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

BCK Capital Management’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-44,000	Closed	-$878K	–	111
2022 Q3	$878K	Buy	+44,000	New	+$580K	0.63%	39

BCK Capital Management's FMTX Position: Q4 2022 in Review

BCK Capital Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 44,000 shares — an estimated $878K sold.

BCK Capital Management first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $878K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

BCK Capital Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
BCK Capital Management sold 44,000 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $878K.
BCK Capital Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
BCK Capital Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $878K in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on BCK Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.